Principal Financial Group Inc. Has $282.70 Million Stock Holdings in HCA Healthcare, Inc. $HCA

Principal Financial Group Inc. reduced its holdings in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) by 0.6% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 597,377 shares of the company’s stock after selling 3,755 shares during the quarter. Principal Financial Group Inc.’s holdings in HCA Healthcare were worth $282,703,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Sumitomo Life Insurance Co. grew its holdings in shares of HCA Healthcare by 1.0% during the 4th quarter. Sumitomo Life Insurance Co. now owns 2,026 shares of the company’s stock valued at $946,000 after purchasing an additional 20 shares during the last quarter. MJP Associates Inc. ADV grew its stake in shares of HCA Healthcare by 2.9% during the fourth quarter. MJP Associates Inc. ADV now owns 749 shares of the company’s stock worth $350,000 after buying an additional 21 shares during the last quarter. Cary Street Partners Investment Advisory LLC lifted its stake in shares of HCA Healthcare by 7.5% in the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company’s stock valued at $140,000 after acquiring an additional 21 shares during the last quarter. Anchyra Partners LLC grew its position in HCA Healthcare by 3.7% during the 1st quarter. Anchyra Partners LLC now owns 587 shares of the company’s stock worth $278,000 after acquiring an additional 21 shares during the last quarter. Finally, Plato Investment Management Ltd raised its position in HCA Healthcare by 0.6% in the fourth quarter. Plato Investment Management Ltd now owns 3,908 shares of the company’s stock valued at $1,833,000 after purchasing an additional 22 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

Trending Headlines about HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on HCA shares. Wall Street Zen downgraded HCA Healthcare from a “buy” rating to a “hold” rating in a research note on Saturday, May 2nd. Jefferies Financial Group set a $450.00 price target on shares of HCA Healthcare in a research report on Tuesday. Cantor Fitzgerald cut their price target on shares of HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating on the stock in a report on Tuesday, July 7th. Royal Bank Of Canada lowered their target price on HCA Healthcare from $593.00 to $534.00 and set an “outperform” rating for the company in a research report on Monday, April 27th. Finally, JPMorgan Chase & Co. reduced their price target on HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 19th. Fourteen equities research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and an average target price of $491.77.

Read Our Latest Stock Report on HCA Healthcare

HCA Healthcare Trading Down 6.7%

Shares of HCA opened at $364.46 on Wednesday. The firm’s fifty day simple moving average is $395.39 and its two-hundred day simple moving average is $458.95. HCA Healthcare, Inc. has a 12 month low of $330.00 and a 12 month high of $556.52. The stock has a market capitalization of $80.85 billion, a P/E ratio of 12.53, a price-to-earnings-growth ratio of 1.24 and a beta of 1.12.

HCA Healthcare (NYSE:HCAGet Free Report) last announced its earnings results on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing the consensus estimate of $7.19 by ($0.04). The business had revenue of $19.11 billion for the quarter, compared to the consensus estimate of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The firm’s revenue for the quarter was up 4.3% on a year-over-year basis. During the same quarter in the previous year, the company earned $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, research analysts predict that HCA Healthcare, Inc. will post 30.07 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th were paid a $0.78 dividend. The ex-dividend date was Tuesday, June 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.9%. HCA Healthcare’s payout ratio is currently 10.73%.

HCA Healthcare Profile

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Featured Articles

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.